nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—SLC6A4—conduct disorder	0.479	0.566	CbGaD
Desipramine—HTR2A—conduct disorder	0.368	0.435	CbGaD
Desipramine—ORM1—saliva—conduct disorder	0.00707	0.234	CbGeAlD
Desipramine—SLC6A2—autonomic nervous system—conduct disorder	0.00543	0.179	CbGeAlD
Desipramine—HTR2A—autonomic nervous system—conduct disorder	0.00326	0.108	CbGeAlD
Desipramine—SMPD1—brain—conduct disorder	0.00143	0.0472	CbGeAlD
Desipramine—CHRM4—brain—conduct disorder	0.00122	0.0402	CbGeAlD
Desipramine—CHRM5—brain—conduct disorder	0.00095	0.0314	CbGeAlD
Desipramine—Protriptyline—SLC6A4—conduct disorder	0.00086	0.108	CrCbGaD
Desipramine—CYP2A6—brain—conduct disorder	0.000768	0.0254	CbGeAlD
Desipramine—SLC22A4—brain—conduct disorder	0.000673	0.0223	CbGeAlD
Desipramine—CHRM2—brain—conduct disorder	0.000652	0.0216	CbGeAlD
Desipramine—SLC6A3—brain—conduct disorder	0.00065	0.0215	CbGeAlD
Desipramine—SLC22A1—brain—conduct disorder	0.000641	0.0212	CbGeAlD
Desipramine—HTR2C—brain—conduct disorder	0.000629	0.0208	CbGeAlD
Desipramine—ADRB1—brain—conduct disorder	0.000617	0.0204	CbGeAlD
Desipramine—SLC22A3—brain—conduct disorder	0.000612	0.0203	CbGeAlD
Desipramine—SLC6A4—brain—conduct disorder	0.000596	0.0197	CbGeAlD
Desipramine—CHRM1—brain—conduct disorder	0.000594	0.0196	CbGeAlD
Desipramine—CHRM3—brain—conduct disorder	0.000531	0.0176	CbGeAlD
Desipramine—HTR1A—brain—conduct disorder	0.000529	0.0175	CbGeAlD
Desipramine—SLC6A2—brain—conduct disorder	0.000525	0.0174	CbGeAlD
Desipramine—Epinastine—HTR2A—conduct disorder	0.00049	0.0618	CrCbGaD
Desipramine—DRD2—brain—conduct disorder	0.000478	0.0158	CbGeAlD
Desipramine—SLC22A5—brain—conduct disorder	0.000445	0.0147	CbGeAlD
Desipramine—Promazine—DRD4—conduct disorder	0.000438	0.0553	CrCbGaD
Desipramine—Maprotiline—HTR2A—conduct disorder	0.000421	0.0532	CrCbGaD
Desipramine—CYP2B6—brain—conduct disorder	0.000387	0.0128	CbGeAlD
Desipramine—Chlorpromazine—DRD4—conduct disorder	0.000385	0.0486	CrCbGaD
Desipramine—HRH1—brain—conduct disorder	0.000378	0.0125	CbGeAlD
Desipramine—Atomoxetine—SLC6A4—conduct disorder	0.000377	0.0476	CrCbGaD
Desipramine—Mianserin—SLC6A4—conduct disorder	0.000369	0.0465	CrCbGaD
Desipramine—CYP2E1—brain—conduct disorder	0.000363	0.012	CbGeAlD
Desipramine—Acepromazine—HTR2A—conduct disorder	0.000341	0.043	CrCbGaD
Desipramine—Clomipramine—SLC6A4—conduct disorder	0.000337	0.0425	CrCbGaD
Desipramine—Nortriptyline—SLC6A4—conduct disorder	0.000329	0.0416	CrCbGaD
Desipramine—HTR2A—brain—conduct disorder	0.000315	0.0104	CbGeAlD
Desipramine—Trimipramine—SLC6A4—conduct disorder	0.00031	0.0391	CrCbGaD
Desipramine—Doxepin—SLC6A4—conduct disorder	0.000296	0.0373	CrCbGaD
Desipramine—Atomoxetine—HTR2A—conduct disorder	0.00029	0.0366	CrCbGaD
Desipramine—CYP2D6—brain—conduct disorder	0.000287	0.0095	CbGeAlD
Desipramine—Mianserin—HTR2A—conduct disorder	0.000283	0.0357	CrCbGaD
Desipramine—Clomipramine—HTR2A—conduct disorder	0.000259	0.0327	CrCbGaD
Desipramine—Nortriptyline—HTR2A—conduct disorder	0.000253	0.0319	CrCbGaD
Desipramine—Trimipramine—HTR2A—conduct disorder	0.000238	0.0301	CrCbGaD
Desipramine—Imipramine—SLC6A4—conduct disorder	0.00023	0.029	CrCbGaD
Desipramine—Promethazine—HTR2A—conduct disorder	0.000229	0.029	CrCbGaD
Desipramine—Amitriptyline—SLC6A4—conduct disorder	0.000229	0.0288	CrCbGaD
Desipramine—Doxepin—HTR2A—conduct disorder	0.000227	0.0287	CrCbGaD
Desipramine—ABCB1—brain—conduct disorder	0.000207	0.00684	CbGeAlD
Desipramine—Promazine—HTR2A—conduct disorder	0.000202	0.0255	CrCbGaD
Desipramine—Chlorpromazine—HTR2A—conduct disorder	0.000178	0.0224	CrCbGaD
Desipramine—Imipramine—HTR2A—conduct disorder	0.000177	0.0223	CrCbGaD
Desipramine—Amitriptyline—HTR2A—conduct disorder	0.000176	0.0222	CrCbGaD
Desipramine—SMPD1—Metabolism—MAOA—conduct disorder	0.000111	0.000965	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—CGA—conduct disorder	0.00011	0.000958	CbGpPWpGaD
Desipramine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000109	0.00095	CbGpPWpGaD
Desipramine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000109	0.00095	CbGpPWpGaD
Desipramine—ADRB1—GPCR ligand binding—DRD4—conduct disorder	0.000109	0.00095	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—CGA—conduct disorder	0.000108	0.000937	CbGpPWpGaD
Desipramine—SMPD1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000108	0.000936	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—CGA—conduct disorder	0.000107	0.000933	CbGpPWpGaD
Desipramine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000107	0.000929	CbGpPWpGaD
Desipramine—ADRB2—GPCR ligand binding—DRD4—conduct disorder	0.000107	0.000929	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000105	0.000917	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000105	0.000912	CbGpPWpGaD
Desipramine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000104	0.000908	CbGpPWpGaD
Desipramine—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000104	0.000908	CbGpPWpGaD
Desipramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000104	0.000906	CbGpPWpGaD
Desipramine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000104	0.000904	CbGpPWpGaD
Desipramine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000104	0.000904	CbGpPWpGaD
Desipramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000104	0.000903	CbGpPWpGaD
Desipramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000103	0.0009	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—CGA—conduct disorder	0.000101	0.000881	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—CGA—conduct disorder	0.0001	0.00087	CbGpPWpGaD
Desipramine—CYP2C19—Biological oxidations—COMT—conduct disorder	9.93e-05	0.000864	CbGpPWpGaD
Desipramine—CYP2C19—Biological oxidations—MAOA—conduct disorder	9.86e-05	0.000858	CbGpPWpGaD
Desipramine—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	9.79e-05	0.000852	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—CGA—conduct disorder	9.78e-05	0.000851	CbGpPWpGaD
Desipramine—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	9.69e-05	0.000843	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—CGA—conduct disorder	9.56e-05	0.000832	CbGpPWpGaD
Desipramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	9.53e-05	0.000829	CbGpPWpGaD
Desipramine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	9.53e-05	0.000829	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—CGA—conduct disorder	9.51e-05	0.000828	CbGpPWpGaD
Desipramine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.35e-05	0.000814	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—CGA—conduct disorder	9.25e-05	0.000805	CbGpPWpGaD
Desipramine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.16e-05	0.000797	CbGpPWpGaD
Desipramine—DRD2—GPCR ligand binding—DRD4—conduct disorder	9.16e-05	0.000797	CbGpPWpGaD
Desipramine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.14e-05	0.000796	CbGpPWpGaD
Desipramine—CYP2D6—Biological oxidations—COMT—conduct disorder	9.13e-05	0.000795	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	9.1e-05	0.000792	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—CGA—conduct disorder	9.08e-05	0.00079	CbGpPWpGaD
Desipramine—CYP2D6—Biological oxidations—MAOA—conduct disorder	9.07e-05	0.000789	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—CGA—conduct disorder	9.05e-05	0.000788	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—CGA—conduct disorder	9.02e-05	0.000785	CbGpPWpGaD
Desipramine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	9.02e-05	0.000785	CbGpPWpGaD
Desipramine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	9.01e-05	0.000784	CbGpPWpGaD
Desipramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9e-05	0.000783	CbGpPWpGaD
Desipramine—HRH1—GPCR ligand binding—DRD4—conduct disorder	9e-05	0.000783	CbGpPWpGaD
Desipramine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.97e-05	0.00078	CbGpPWpGaD
Desipramine—CHRM1—GPCR ligand binding—DRD4—conduct disorder	8.97e-05	0.00078	CbGpPWpGaD
Desipramine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	8.94e-05	0.000778	CbGpPWpGaD
Desipramine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.94e-05	0.000778	CbGpPWpGaD
Desipramine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.94e-05	0.000778	CbGpPWpGaD
Desipramine—CHRM3—GPCR ligand binding—DRD4—conduct disorder	8.94e-05	0.000778	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	8.93e-05	0.000777	CbGpPWpGaD
Desipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.89e-05	0.000774	CbGpPWpGaD
Desipramine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.85e-05	0.00077	CbGpPWpGaD
Desipramine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	8.85e-05	0.00077	CbGpPWpGaD
Desipramine—CHRM4—GPCR ligand binding—HTR2A—conduct disorder	8.68e-05	0.000755	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	8.45e-05	0.000735	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—CGA—conduct disorder	8.4e-05	0.000731	CbGpPWpGaD
Desipramine—CHRM5—GPCR ligand binding—HTR2A—conduct disorder	8.31e-05	0.000723	CbGpPWpGaD
Desipramine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	8.27e-05	0.00072	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—CGA—conduct disorder	8.26e-05	0.000719	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—CGA—conduct disorder	8.24e-05	0.000717	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—CGA—conduct disorder	8.22e-05	0.000715	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—CGA—conduct disorder	8.19e-05	0.000713	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—CGA—conduct disorder	8.11e-05	0.000706	CbGpPWpGaD
Desipramine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.85e-05	0.000683	CbGpPWpGaD
Desipramine—CYP1A2—Biological oxidations—COMT—conduct disorder	7.74e-05	0.000673	CbGpPWpGaD
Desipramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.71e-05	0.000671	CbGpPWpGaD
Desipramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.68e-05	0.000669	CbGpPWpGaD
Desipramine—CYP1A2—Biological oxidations—MAOA—conduct disorder	7.68e-05	0.000669	CbGpPWpGaD
Desipramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.66e-05	0.000667	CbGpPWpGaD
Desipramine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	7.63e-05	0.000664	CbGpPWpGaD
Desipramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.58e-05	0.00066	CbGpPWpGaD
Desipramine—CHRM4—GPCR downstream signaling—DRD4—conduct disorder	7.52e-05	0.000654	CbGpPWpGaD
Desipramine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	7.35e-05	0.00064	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CGA—conduct disorder	7.2e-05	0.000627	CbGpPWpGaD
Desipramine—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	7.2e-05	0.000626	CbGpPWpGaD
Desipramine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	7.14e-05	0.000622	CbGpPWpGaD
Desipramine—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	7.12e-05	0.00062	CbGpPWpGaD
Desipramine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	7.01e-05	0.00061	CbGpPWpGaD
Desipramine—ADRB2—GPCR ligand binding—HTR2A—conduct disorder	6.96e-05	0.000606	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CGA—conduct disorder	6.89e-05	0.0006	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—DRD4—conduct disorder	6.82e-05	0.000594	CbGpPWpGaD
Desipramine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	6.81e-05	0.000593	CbGpPWpGaD
Desipramine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	6.77e-05	0.00059	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—CGA—conduct disorder	6.72e-05	0.000585	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	6.58e-05	0.000573	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—DRD4—conduct disorder	6.54e-05	0.000569	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—CGA—conduct disorder	6.26e-05	0.000545	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—CGA—conduct disorder	6.17e-05	0.000537	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	6.17e-05	0.000537	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—DRD4—conduct disorder	6.03e-05	0.000525	CbGpPWpGaD
Desipramine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	5.98e-05	0.00052	CbGpPWpGaD
Desipramine—CYP3A4—Biological oxidations—COMT—conduct disorder	5.97e-05	0.00052	CbGpPWpGaD
Desipramine—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.93e-05	0.000516	CbGpPWpGaD
Desipramine—DRD2—Circadian rythm related genes—EP300—conduct disorder	5.93e-05	0.000516	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CGA—conduct disorder	5.91e-05	0.000514	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	5.9e-05	0.000513	CbGpPWpGaD
Desipramine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	5.89e-05	0.000513	CbGpPWpGaD
Desipramine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	5.87e-05	0.000511	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	5.87e-05	0.000511	CbGpPWpGaD
Desipramine—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	5.85e-05	0.000509	CbGpPWpGaD
Desipramine—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	5.83e-05	0.000508	CbGpPWpGaD
Desipramine—CHRM1—Circadian rythm related genes—EP300—conduct disorder	5.8e-05	0.000505	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—CGA—conduct disorder	5.79e-05	0.000504	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CGA—conduct disorder	5.78e-05	0.000503	CbGpPWpGaD
Desipramine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	5.78e-05	0.000503	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—WASF1—conduct disorder	5.77e-05	0.000502	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CGA—conduct disorder	5.65e-05	0.000492	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CGA—conduct disorder	5.62e-05	0.000489	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—DRD4—conduct disorder	5.6e-05	0.000487	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—WASF1—conduct disorder	5.53e-05	0.000481	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—DRD4—conduct disorder	5.48e-05	0.000477	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	5.36e-05	0.000466	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	5.33e-05	0.000464	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	5.18e-05	0.000451	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	5.09e-05	0.000443	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	5.08e-05	0.000442	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	5.07e-05	0.000441	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	5.05e-05	0.00044	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	5e-05	0.000435	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—CGA—conduct disorder	4.98e-05	0.000433	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CGA—conduct disorder	4.96e-05	0.000432	CbGpPWpGaD
Desipramine—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	4.9e-05	0.000427	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CGA—conduct disorder	4.88e-05	0.000425	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—CGA—conduct disorder	4.88e-05	0.000424	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CGA—conduct disorder	4.87e-05	0.000424	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CGA—conduct disorder	4.85e-05	0.000422	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CGA—conduct disorder	4.84e-05	0.000421	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—COMT—conduct disorder	4.84e-05	0.000421	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—MAOA—conduct disorder	4.8e-05	0.000418	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CGA—conduct disorder	4.79e-05	0.000417	CbGpPWpGaD
Desipramine—SMPD1—Metabolism—EP300—conduct disorder	4.79e-05	0.000417	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—WASF1—conduct disorder	4.73e-05	0.000412	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—DRD4—conduct disorder	4.7e-05	0.000409	CbGpPWpGaD
Desipramine—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	4.7e-05	0.000409	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—WASF1—conduct disorder	4.63e-05	0.000403	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.63e-05	0.000403	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—DRD4—conduct disorder	4.62e-05	0.000402	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—DRD4—conduct disorder	4.6e-05	0.000401	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—DRD4—conduct disorder	4.59e-05	0.000399	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—COMT—conduct disorder	4.57e-05	0.000398	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	4.54e-05	0.000395	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—MAOA—conduct disorder	4.54e-05	0.000395	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—WASF1—conduct disorder	4.53e-05	0.000394	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.5e-05	0.000392	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	4.45e-05	0.000388	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	4.26e-05	0.000371	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—DRD4—conduct disorder	4.03e-05	0.000351	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	4.02e-05	0.00035	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—WASF1—conduct disorder	3.97e-05	0.000346	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—HTR2A—conduct disorder	3.94e-05	0.000342	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—WASF1—conduct disorder	3.91e-05	0.00034	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—WASF1—conduct disorder	3.9e-05	0.00034	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—WASF1—conduct disorder	3.89e-05	0.000339	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—WASF1—conduct disorder	3.88e-05	0.000338	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—DRD4—conduct disorder	3.86e-05	0.000336	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	3.85e-05	0.000335	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—WASF1—conduct disorder	3.84e-05	0.000334	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.83e-05	0.000333	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	3.82e-05	0.000333	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CGA—conduct disorder	3.76e-05	0.000327	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CGA—conduct disorder	3.67e-05	0.00032	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	3.65e-05	0.000318	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—HTR2A—conduct disorder	3.57e-05	0.000311	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	3.49e-05	0.000304	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.48e-05	0.000303	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CGA—conduct disorder	3.46e-05	0.000301	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.38e-05	0.000294	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	3.32e-05	0.000289	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—DRD4—conduct disorder	3.31e-05	0.000288	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	3.31e-05	0.000288	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	3.3e-05	0.000287	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	3.26e-05	0.000284	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—DRD4—conduct disorder	3.24e-05	0.000282	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—DRD4—conduct disorder	3.16e-05	0.000275	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.15e-05	0.000274	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	3.07e-05	0.000267	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—COMT—conduct disorder	3.03e-05	0.000264	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—MAOA—conduct disorder	3.01e-05	0.000262	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	3.01e-05	0.000262	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	3e-05	0.000261	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	2.99e-05	0.00026	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	2.96e-05	0.000258	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CGA—conduct disorder	2.93e-05	0.000255	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—COMT—conduct disorder	2.83e-05	0.000246	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—MAOA—conduct disorder	2.81e-05	0.000244	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—COMT—conduct disorder	2.79e-05	0.000242	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—DRD4—conduct disorder	2.78e-05	0.000242	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—MAOA—conduct disorder	2.77e-05	0.000241	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.73e-05	0.000238	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—DRD4—conduct disorder	2.73e-05	0.000237	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—DRD4—conduct disorder	2.72e-05	0.000237	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—DRD4—conduct disorder	2.71e-05	0.000236	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—DRD4—conduct disorder	2.68e-05	0.000234	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HTR2A—conduct disorder	2.63e-05	0.000229	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—COMT—conduct disorder	2.61e-05	0.000227	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—MAOA—conduct disorder	2.59e-05	0.000226	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HTR2A—conduct disorder	2.52e-05	0.000219	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CGA—conduct disorder	2.26e-05	0.000197	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—COMT—conduct disorder	2.25e-05	0.000196	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—MAOA—conduct disorder	2.23e-05	0.000194	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—COMT—conduct disorder	2.2e-05	0.000192	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—MAOA—conduct disorder	2.19e-05	0.00019	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HTR2A—conduct disorder	2.16e-05	0.000188	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HTR2A—conduct disorder	2.11e-05	0.000184	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—EP300—conduct disorder	2.07e-05	0.000181	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	2.06e-05	0.00018	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	2.05e-05	0.000179	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—EP300—conduct disorder	1.96e-05	0.000171	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.81e-05	0.000158	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.78e-05	0.000155	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HTR2A—conduct disorder	1.77e-05	0.000154	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HTR2A—conduct disorder	1.77e-05	0.000154	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	1.75e-05	0.000152	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—COMT—conduct disorder	1.7e-05	0.000148	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—MAOA—conduct disorder	1.69e-05	0.000147	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—COMT—conduct disorder	1.66e-05	0.000144	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—MAOA—conduct disorder	1.65e-05	0.000143	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.64e-05	0.000142	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—COMT—conduct disorder	1.56e-05	0.000136	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—MAOA—conduct disorder	1.55e-05	0.000135	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—EP300—conduct disorder	1.39e-05	0.000121	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—EP300—conduct disorder	1.33e-05	0.000116	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—COMT—conduct disorder	1.32e-05	0.000115	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—MAOA—conduct disorder	1.31e-05	0.000114	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—EP300—conduct disorder	1.3e-05	0.000113	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.27e-05	0.000111	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—EP300—conduct disorder	1.21e-05	0.000106	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—EP300—conduct disorder	1.19e-05	0.000104	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EP300—conduct disorder	1.14e-05	9.95e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—EP300—conduct disorder	1.12e-05	9.75e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EP300—conduct disorder	1.12e-05	9.73e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EP300—conduct disorder	1.09e-05	9.52e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EP300—conduct disorder	1.09e-05	9.47e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—COMT—conduct disorder	1.02e-05	8.89e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MAOA—conduct disorder	1.01e-05	8.83e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—EP300—conduct disorder	9.64e-06	8.39e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EP300—conduct disorder	9.6e-06	8.36e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EP300—conduct disorder	9.45e-06	8.22e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—EP300—conduct disorder	9.44e-06	8.22e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EP300—conduct disorder	9.43e-06	8.2e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EP300—conduct disorder	9.4e-06	8.18e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EP300—conduct disorder	9.37e-06	8.15e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EP300—conduct disorder	9.28e-06	8.07e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—EP300—conduct disorder	7.28e-06	6.34e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—EP300—conduct disorder	7.11e-06	6.19e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—EP300—conduct disorder	6.7e-06	5.83e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—EP300—conduct disorder	5.67e-06	4.94e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—EP300—conduct disorder	4.38e-06	3.81e-05	CbGpPWpGaD
